10 Hot Biotech Stocks Under $5 to Buy
On June 4, 2026, CNBC reported that global biopharma M&A is on track for its strongest year since the pre-pandemic peak seven years ago.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GordonMD Global Investments Craig Gordon | 10,024,909 | $30,174,976 | +144% | 14.6% |
| 2. | Laurion Capital Management Benjamin A. Smith | 4,900,888 | $14,751,673 | -2% | 0.38% |
| 3. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 966,459 | $2,909,041 | +391% | 0.78% |
| 4. | Palo Alto Investors William Leland Edwards | 864,277 | $2,601,474 | -15% | 0.36% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 830,544 | $2,499,936 | +135% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.96 | 83,400 | $163,464.00 | 1,199,143 | 2024-11-26 | Filing | |
| $2.00 | 5,450 | $10,900.00 | 1,115,743 | 2024-11-26 | Filing | |
| $1.87 | 8,000 | $14,960.00 | 818,532 | 2023-09-28 | Filing | |
| $1.87 | 2,500 | $4,675.00 | 226,937 | 2023-09-27 | Filing | |
| $1.85 | 6,426 | $11,867.54 | 810,532 | 2023-09-27 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.06 | 35,000 | $107,100.00 | 38,741 | 2026-06-30 | Filing | |
| $1.03 | 13,896 | $14,361.52 | 81,309 | 2025-04-21 | Filing | |
| $0.97 | 200 | $194.00 | 95,205 | 2025-04-17 | Filing | |
| $0.97 | 1,400 | $1,361.78 | 95,405 | 2025-04-14 | Filing | |
| $2.10 | 8,541 | $17,936.10 | 2,403,882 | 2023-09-18 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,032,770 | $19,480,773 | 11.43% | |
| 2. | 2,075,997 | $6,248,751 | 0% | |
| 3. | 867,934 | $2,612,481 | 0% | |
| 4. | 591,849 | $1,782,698 | 0% | |
| 5. | 428,606 | $1,290,104 | 0% |